Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline.

Peter Vincent JenkinsAnnette BowyerClive BurgessElaine Gray Steve KitchenPaul MurphySean PlattonAnne RiddellPratima Chowdary William A Lester

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)

Knowledge of the effect of emicizumab on coagulation tests and factor assays is required to ensure appropriate testing and monitoring of therapy in patients receiving this drug.

Keyphrases

healthcare
high throughput
emergency department
stem cells
cross sectional
medical students
bone marrow
adverse drug
combination therapy
drug induced
cell therapy